Exozymes (EXOZ) Other Non-Current Liabilities (2023 - 2024)
Exozymes (EXOZ) has disclosed Other Non-Current Liabilities for 2 consecutive years, with $1.0 million as the latest value for Q3 2024.
- Quarterly Other Non-Current Liabilities changed N/A to $1.0 million in Q3 2024 from the year-ago period, while the trailing twelve-month figure was $1.0 million through Sep 2024, changed N/A year-over-year, with the annual reading at $1.0 million for FY2023, N/A changed from the prior year.
- Other Non-Current Liabilities for Q3 2024 was $1.0 million at Exozymes, roughly flat from $1.0 million in the prior quarter.
- The five-year high for Other Non-Current Liabilities was $1.0 million in Q4 2023, with the low at $1.0 million in Q4 2023.